- Analytica Investor
- Posts
- 👀 The setup before the re-rating
👀 The setup before the re-rating
inTEST is still trading on skepticism, even as demand and backlog move the other way
Matthias Schneider
February 08, 2026
In partnership with
Welcome Investors!
inTEST Corporation (NYSE: INTT) is trading in a zone that experienced investors recognize instantly. The business is functioning, the balance sheet is sound, yet the stock remains discounted because confidence has not fully returned.
Shares sit near $10 not because $INTT ( ▼ 2.72% ) lacks relevance, but because the market is still anchored to a period of uneven execution and cyclical uncertainty.
Revenue softness through 2025 and a visible Q3 miss gave skeptics exactly what they needed to stay cautious. Layer on acquisition complexity and the lingering perception that inTEST is merely a small, cyclical semiconductor equipment supplier, and the result is a compressed multiple.
This is not a verdict on the business. It is a pause. A demand for proof. Markets are not saying no, they are saying not yet.
Matthias Schneider
Editor at Analytica Investor